What is the prevalence of Trisomy 13 Syndrome / Patau Syndrome?
How many people does Trisomy 13 Syndrome / Patau Syndrome affect? Does it have the same prevalence in men and women? And in the different countries?
Trisomy 13 Syndrome, also known as Patau Syndrome, is a rare chromosomal disorder caused by the presence of an extra copy of chromosome 13. It is characterized by severe developmental abnormalities and multiple organ defects. The prevalence of Trisomy 13 Syndrome is estimated to be approximately 1 in 10,000 to 1 in 16,000 live births. Sadly, most affected individuals do not survive beyond the first year of life due to the severity of their medical complications. Early diagnosis and comprehensive medical care are crucial in managing this condition.
Trisomy 13 Syndrome, also known as Patau Syndrome, is a rare chromosomal disorder caused by the presence of an extra copy of chromosome 13 in cells. It is characterized by multiple physical abnormalities and intellectual disabilities. The prevalence of Trisomy 13 Syndrome is estimated to be around 1 in 10,000 to 1 in 16,000 live births.
This condition affects both males and females equally, and it occurs randomly without any known risk factors or hereditary patterns. The extra genetic material disrupts normal development, leading to various birth defects such as cleft lip and palate, heart defects, brain abnormalities, and extra fingers or toes.
Unfortunately, Trisomy 13 Syndrome is associated with a high mortality rate, and many affected infants do not survive beyond the first year of life. Those who do survive often have severe intellectual disabilities and require extensive medical care.
Diagnosis of Trisomy 13 Syndrome is typically made through genetic testing, such as amniocentesis or chorionic villus sampling, during pregnancy or shortly after birth. Although there is no cure for this condition, treatment focuses on managing the associated health issues and providing supportive care to improve the quality of life for affected individuals.
